Rodolfo brings with him a wealth of rich experience from commercial, marketing, and general management roles across several multinational companies
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
Air purification system achieves Intertek zero ozone certification
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
John served as General Manager for Catalent Pharma Solutions in St. Petersburg, Florida
The sale is expected to close in the first quarter of 2022
EBITDA from Continuing Operations at Rs. 582 crore recorded a growth of 31 %.
Ascent Meditech has set benchmarks in introducing pain management products in India. The company has embarked on a new marketing campaign as it plans to enter new markets. Rajiv Mistry, Founder & Managing Director, Ascent Group shares his perspective with Thomas C Thottathil on the road ahead for the company and industry
ICICI Direct’s analysis of Cipla’s Q3FY22 results
Subscribe To Our Newsletter & Stay Updated
